These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
358 related items for PubMed ID: 8456422
1. A higher than expected incidence of factor VIII inhibitors in multitransfused haemophilia A patients treated with an intermediate purity pasteurized factor VIII concentrate. Peerlinck K, Arnout J, Gilles JG, Saint-Remy JM, Vermylen J. Thromb Haemost; 1993 Feb 01; 69(2):115-8. PubMed ID: 8456422 [Abstract] [Full Text] [Related]
2. Factor VIII inhibitors in previously treated haemophilia A patients with a double virus-inactivated plasma derived factor VIII concentrate. Peerlinck K, Arnout J, Di Giambattista M, Gilles JG, Laub R, Jacquemin M, Saint-Remy JM, Vermylen J. Thromb Haemost; 1997 Jan 01; 77(1):80-6. PubMed ID: 9031454 [Abstract] [Full Text] [Related]
3. Occurrence of inhibitors in previously untreated or minimally treated patients with haemophilia A after exposure to a plasma-derived solvent-detergent factor VIII concentrate. Gringeri A, Monzini M, Tagariello G, Scaraggi FA, Mannucci PM, Emoclot15 Study Members. Haemophilia; 2006 Mar 01; 12(2):128-32. PubMed ID: 16476086 [Abstract] [Full Text] [Related]
4. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A. Sawecka J, Skulimowska J, Windyga J, Lopaciuk S, Kościelak J. Arch Immunol Ther Exp (Warsz); 2005 Mar 01; 53(4):352-6. PubMed ID: 16088320 [Abstract] [Full Text] [Related]
7. Incidence of inhibitors in haemophiliacs. A review of the literature. Scharrer I, Neutzling O. Blood Coagul Fibrinolysis; 1993 Oct 01; 4(5):753-8. PubMed ID: 8292725 [Abstract] [Full Text] [Related]
11. Inhibitors in German hemophilia A patients treated with a double virus inactivated factor VIII concentrate bind to the C2 domain of FVIII light chain. Laub R, Di Giambattista M, Fondu P, Brackmann HH, Lenk H, Saenko EL, Felch M, Scandella D. Thromb Haemost; 1999 Jan 01; 81(1):39-44. PubMed ID: 9974372 [Abstract] [Full Text] [Related]
12. CD4 cells in HIV-1 infected hemophiliacs: effect of factor VIII concentrates. Goldsmith JM, Deutsche J, Tang M, Green D. Thromb Haemost; 1991 Oct 01; 66(4):415-9. PubMed ID: 1839091 [Abstract] [Full Text] [Related]
15. Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response. Gringeri A, Musso R, Mazzucconi MG, Piseddu G, Schiavoni M, Pignoloni P, Mannucci PM, RITS-FITNHES Study Group. Haemophilia; 2007 Jul 01; 13(4):373-9. PubMed ID: 17610550 [Abstract] [Full Text] [Related]
17. CD4+ counts before and after switching to monoclonal high-purity factor VIII concentrate in HIV-infected haemophilic patients. Sabin C, Pasi J, Phillips A, Elford J, Janossy G, Lee C. Thromb Haemost; 1994 Aug 01; 72(2):214-7. PubMed ID: 7831654 [Abstract] [Full Text] [Related]
18. A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucrose. Rubinger M, Lillicrap D, Rivard GE, Teitel J, Carcao M, Hensman C, Walker I, Association of Hemophilia Clinic Directors of Canada. Haemophilia; 2008 Mar 01; 14(2):281-6. PubMed ID: 18194308 [Abstract] [Full Text] [Related]